| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |